Spark up: US FDA approves first gene therapy for genetic disease
Spark Therapeutics has received US approval for Luxturna (voretigene neparvovec-rzyl), its one-time gene therapy treatment for an inherited form of vision loss.
Archives for December 20, 2017
3M aims at double-digit growth in $5.5bn biopharma filtration market
The full integration of filtration tech company Membrana is driving double-digit growth rate for 3M’s biopharma purification business, the firm says.
ADCs: Global service demand buoyed by approvals, WuXi
Antibody-drug conjugates (ADCs) are one of the “hottest areas of research” says STA Pharmaceutical and WuXi Biologics which are investing in conjugation and fill/finish capabilities in China.